Kyverna Therapeutics Inc (KYTX)

$7.18 +1.77 (32.72%)
Market Cap 233.96M
Revenue (ttm) 0.00
Net Income (ttm) -127.48M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 6,628,000
Avg Vol 484,462
Day's Range N/A - N/A
Shares Out 43.25M
Stochastic %K 77%
Beta 3.72
Analysts Strong Sell
Price Target $19.75

Company Profile

Kyverna Therapeutics, Inc., clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases. The company's lead product candidate is KYV-101, an autologous CD19 CAR T-cell product candidate for the treatment of stiff person syndrome, myasthenia gravis, lupus nephritis, and rapid whole blood process. It is also developing KYV-102, an autologous CD19 CAR T-cell product candidate with whole blood rapid manufacturing, as well as KYV-201, an alloge...

Industry: Biotechnology
Sector: Healthcare
Phone: 510 925 2492
Address:
5980 Horton Street, Suite 550, EmeryVille, United States
iKeepGrinding
iKeepGrinding Oct. 9 at 3:03 AM
$MSN 0 shares to borrow, let the short squeeze begin! High on watch. $PRHI $ATON $KYTX $ABVE
1 · Reply
StockScanners
StockScanners Oct. 9 at 1:24 AM
$KYTX keep watch if this holds above 6.75
0 · Reply
winningallday
winningallday Oct. 8 at 8:22 PM
$KYTX pump this 🐱 with cum
0 · Reply
Tinywins
Tinywins Oct. 8 at 8:18 PM
$KYTX whats their financial status rn? Do they have cash to burn?
1 · Reply
GSP
GSP Oct. 8 at 7:58 PM
$SCWO $KYTX $BENF $DVLT $PLUG
1 · Reply
patb99
patb99 Oct. 8 at 7:38 PM
$KYTX wow 😮
0 · Reply
patb99
patb99 Oct. 8 at 7:20 PM
$KYTX and boom 7,01$
0 · Reply
intrader
intrader Oct. 8 at 6:48 PM
$KYTX
0 · Reply
BlakeCanyon50
BlakeCanyon50 Oct. 8 at 6:39 PM
$KYTX 🤘🏼
0 · Reply
patb99
patb99 Oct. 8 at 6:38 PM
$KYTX VWAP at 7$ 🧐
0 · Reply
Latest News on KYTX
Kyverna Therapeutics Highlights Potential of KYV-101 in Multiple Sclerosis with Data from Phase 1 Investigator-Initiated Trials to be Presented at ECTRIMS

Sep 24, 2025, 9:05 AM EDT - 14 days ago

Kyverna Therapeutics Highlights Potential of KYV-101 in Multiple Sclerosis with Data from Phase 1 Investigator-Initiated Trials to be Presented at ECTRIMS

Kyverna Therapeutics to Highlight Interim Phase 2 Data from KYV-101 KYSA-6 Study in Myasthenia Gravis at AANEM 2025

Sep 15, 2025, 1:02 PM EDT - 23 days ago

Kyverna Therapeutics to Highlight Interim Phase 2 Data from KYV-101 KYSA-6 Study in Myasthenia Gravis at AANEM 2025

Kyverna Therapeutics Highlights Neuroimmunology CAR T Franchise and Registrational Phase 3 Trial Design in Myasthenia Gravis at Virtual KOL Event

Aug 28, 2025, 8:00 AM EDT - 5 weeks ago

Kyverna Therapeutics Highlights Neuroimmunology CAR T Franchise and Registrational Phase 3 Trial Design in Myasthenia Gravis at Virtual KOL Event

Kyverna Therapeutics to Present at Upcoming Investor Conferences in September

Aug 25, 2025, 4:02 PM EDT - 6 weeks ago

Kyverna Therapeutics to Present at Upcoming Investor Conferences in September

Kyverna Sets Pace In Race For Autoimmune CAR-T Approval By 2026

Aug 20, 2025, 3:29 PM EDT - 7 weeks ago

Kyverna Sets Pace In Race For Autoimmune CAR-T Approval By 2026

Kyverna Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results

Aug 12, 2025, 4:02 PM EDT - 2 months ago

Kyverna Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results

Kyverna Therapeutics to Host Virtual KOL Event to Highlight Neuroimmunology CAR T Franchise

Jul 29, 2025, 8:30 AM EDT - 2 months ago

Kyverna Therapeutics to Host Virtual KOL Event to Highlight Neuroimmunology CAR T Franchise

Kyverna Therapeutics to Present at the Jefferies Global Healthcare Conference

May 28, 2025, 4:02 PM EDT - 4 months ago

Kyverna Therapeutics to Present at the Jefferies Global Healthcare Conference

With Trials In Motion, Cash To 2027, Can Kyverna's Next Data Drop Turn The Stock Around?

May 27, 2025, 3:42 PM EDT - 4 months ago

With Trials In Motion, Cash To 2027, Can Kyverna's Next Data Drop Turn The Stock Around?

Kyverna Therapeutics Provides Business Update and Reports First Quarter 2025 Financial Results

May 13, 2025, 4:02 PM EDT - 5 months ago

Kyverna Therapeutics Provides Business Update and Reports First Quarter 2025 Financial Results

Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 27, 2025, 4:02 PM EDT - 6 months ago

Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Kyverna: 2 Myasthenia Gravis Program Catalysts On Deck In 2025

Mar 21, 2025, 11:29 AM EDT - 7 months ago

Kyverna: 2 Myasthenia Gravis Program Catalysts On Deck In 2025

Kyverna Therapeutics to Present at the Leerink Partners Global Biopharma Conference

Mar 3, 2025, 4:05 PM EST - 7 months ago

Kyverna Therapeutics to Present at the Leerink Partners Global Biopharma Conference

KYTX Deadline: KYTX Investors Have Opportunity to Lead Kyverna Therapeutics, Inc. Securities Lawsuit

Feb 7, 2025, 11:42 AM EST - 8 months ago

KYTX Deadline: KYTX Investors Have Opportunity to Lead Kyverna Therapeutics, Inc. Securities Lawsuit

Investors in Kyverna Therapeutics, Inc. Should Contact The Gross Law Firm Before February 7, 2025 to Discuss Your Rights – KYTX

Feb 6, 2025, 1:51 PM EST - 8 months ago

Investors in Kyverna Therapeutics, Inc. Should Contact The Gross Law Firm Before February 7, 2025 to Discuss Your Rights – KYTX

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics

Feb 5, 2025, 11:54 AM EST - 8 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics

Final Deadline for the Kyverna Therapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - KYTX

Feb 4, 2025, 3:51 AM EST - 8 months ago

Final Deadline for the Kyverna Therapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - KYTX

KYTX Investors Have Opportunity to Lead Kyverna Therapeutics, Inc. Securities Lawsuit

Jan 27, 2025, 3:22 PM EST - 9 months ago

KYTX Investors Have Opportunity to Lead Kyverna Therapeutics, Inc. Securities Lawsuit

Kyverna Therapeutics Appoints Naji Gehchan, MD, MBA, as Chief Medical and Development Officer

Jan 21, 2025, 4:05 PM EST - 9 months ago

Kyverna Therapeutics Appoints Naji Gehchan, MD, MBA, as Chief Medical and Development Officer

iKeepGrinding
iKeepGrinding Oct. 9 at 3:03 AM
$MSN 0 shares to borrow, let the short squeeze begin! High on watch. $PRHI $ATON $KYTX $ABVE
1 · Reply
StockScanners
StockScanners Oct. 9 at 1:24 AM
$KYTX keep watch if this holds above 6.75
0 · Reply
winningallday
winningallday Oct. 8 at 8:22 PM
$KYTX pump this 🐱 with cum
0 · Reply
Tinywins
Tinywins Oct. 8 at 8:18 PM
$KYTX whats their financial status rn? Do they have cash to burn?
1 · Reply
GSP
GSP Oct. 8 at 7:58 PM
$SCWO $KYTX $BENF $DVLT $PLUG
1 · Reply
patb99
patb99 Oct. 8 at 7:38 PM
$KYTX wow 😮
0 · Reply
patb99
patb99 Oct. 8 at 7:20 PM
$KYTX and boom 7,01$
0 · Reply
intrader
intrader Oct. 8 at 6:48 PM
$KYTX
0 · Reply
BlakeCanyon50
BlakeCanyon50 Oct. 8 at 6:39 PM
$KYTX 🤘🏼
0 · Reply
patb99
patb99 Oct. 8 at 6:38 PM
$KYTX VWAP at 7$ 🧐
0 · Reply
Bullflagz
Bullflagz Oct. 8 at 6:33 PM
$KYTX possible top small entry
0 · Reply
blocktrade
blocktrade Oct. 8 at 6:14 PM
$KYTX there is definitely something else going on. Volume is 5mm. The wells pt news came out 6:30 am est.
1 · Reply
CheckingMorons
CheckingMorons Oct. 8 at 6:10 PM
$KYTX who is pumping this shit
1 · Reply
patb99
patb99 Oct. 8 at 5:31 PM
$KYTX VWAP at 6,99$ 🧐
0 · Reply
CoachHendo
CoachHendo Oct. 8 at 5:23 PM
$KYTX, room to run?
0 · Reply
belugatrade
belugatrade Oct. 8 at 4:51 PM
$KYTX very nice rounding bottom with 100% price target
0 · Reply
topstockalerts
topstockalerts Oct. 8 at 4:48 PM
$KYTX Looking good!
0 · Reply
gsmkam
gsmkam Oct. 8 at 4:42 PM
$KYTX let’s push it above 7.50
0 · Reply
winwithme
winwithme Oct. 8 at 4:06 PM
$KYTX ✅
0 · Reply
ThomasTrainTrader
ThomasTrainTrader Oct. 8 at 4:03 PM
$KYTX was a little off on the timeframe but it still hit big
0 · Reply
Leshea67
Leshea67 Oct. 8 at 3:55 PM
$KYTX if it get past $8 could see a run...
0 · Reply
Titan202
Titan202 Oct. 8 at 3:55 PM
$KYTX Could this be the next pharma stock to fly 🤔
0 · Reply